An Industry Changing Advance

INSTANT RESULTS

INSTANT RESULTS

Unlike Biological Indicators, Enzyme Indicators give immediate power through knowledge. Immediate and verified sterilizer lethality confirmation, this is a must-have technology for any environment needing fast decontamination performance validation.

QUANTIFIABLE DATA CAPTURE

QUANTIFIABLE DATA CAPTURE

EI READERS provide quantifiable, linear readings that provide users with substantially more information than the current BIs. Enzyme Indicators can act as early warning systems – allowing performance monitoring, threshold release and automatic data capture.

LIFE-CHANGING IMPLICATIONS

LIFE-CHANGING IMPLICATIONS

From being faster to bring operating theatres back into service to ongoing equipment validation and immediate medical batch release the benefits are tangible – this revolutionary science may save lives.

AUDIT & APPROVAL

AUDIT & APPROVAL

Enzyme Indicators, and tAK validation provide the sterility assurance needed to satisfy the demonstrated lethality audit process quickly and easily – and satisfy the regulator’s scrutiny.

100% PERFORMANCE ASSURANCE

100% PERFORMANCE ASSURANCE

Enzyme Indicators,  are manufactured to eliminate rogue results and include an optional onsite self-validation process making them perfect for decontamination verification, infection prevention, sterility assurance and aseptic manufacturing.

SIMPLE & EASY TO USE TESTING

SIMPLE & EASY TO USE TESTING

Enzyme indicators require no incubation. A simple process, performed by a self-calibrating, fully-validated reader provides instant decontamination verification.

Book Your Free, Live On-Site Demo Now

Do your work for one of these companies?

jnj
roche
Pfizer
Novartis
bayer
merick
gsk
sanofi
gilead
AstraZeneca

Click on your logo to find out how we can help you

We are looking for a few select pharma partners to work with us over the next 12 months in spearheading the advancement of this new alternative to biological indicators. Enzyme Indicators represent a multi-million pound investment – currently protected globally by in excess of thirty patents. As part of continued research into Enzyme Indicators (EIs), Protak Scientific, working with Public Health England (PHE) has commissioned a further study. Over the next 12 months Protak and PHE will be working with only five selected pharmaceutical partners in trialing EIs in a manufacturing environment. These partners will gain invaluable insight, insider knowledge and will benefit from initially exclusive access to Protak’s data centres.

We’ll leave it to the pharma Financial Directors to work out the savings to be made in man-hours and by avoiding product recalls and providing instant assured product release. For the Quality Directors EIs offer complete assurance and peace-of-mind, satisfying that the process is continually monitored and verified; providing the very first immediate verification tool available. This quantifiable data with pre-emptive knowledge can provide an early warning. The absolute purity of this data vs traditional biological indicators makes this technology such a revelation. The first trial partner is already benefitting from the cutting-edge technology – with other companies in negotiations. To become a Protak partner – please get in touch

Traditional Biological Indicators 7-day Incubation Reduced To

Under Two Minutes

Keep Up To Date

  • Product should never be released without knowing that decontamination processes were carried out effectively.

    Senior Scientist Public Health England
  • Pharmaceutical auditing and batch release will never be the same again.

    Senior Scientist Public Health England
  • Enzyme Indicators are the future - giving instant and quantifiable results.

    Compounding Facility Manager in Europe
  • It's an advance so great that it will change society as we know it.

    Compounding Facility Manager in Europe
  • Enzyme Indicators are set to transform pharmaceutical manufacturing and processing...

    Protak Managing Director
  • Some sites have speculated a 20% increase in production - resulting from time savings alone.

    Protak Managing Director